intelligence360
  • SUBSCRIBE
  • About us
  • Video News Daily
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

Allara Health Raises $26 Million in Series B Funding to Revolutionize Women’s Hormonal Healthcare

Allara Health Raises $26 Million in Series B Funding to Revolutionize Women’s Hormonal Healthcare

February 7, 2025 Sarah Bruhn

Led by Index Ventures with participation from GV (Google Ventures), this funding round underscores milestone growth, cross-country expansion, and new Chief Medical Officer

NEW YORK, Jan. 24, 2025 /PRNewswire/ — Allara Health, the virtual care platform bridging the care divide for women battling chronic hormonal conditions, announced today its $26 million Series B funding round, bringing the company’s total funding to $38.5 million. Index Ventures led the round and partner Martin Mignot will join Allara’s board. Existing investor GV (Google Ventures) also participated in the round. This Series B investment will allow Allara to bring specialized care to women nationwide struggling with hormonal conditions.  

Today, 1 in 3 women will battle a chronic hormonal condition in their lifetimes, including polycystic ovarian syndrome (PCOS), endometriosis, and hypothyroidism – all of which can cause health challenges like infertility, high-risk pregnancies, obesity, and diabetes. For those struggling, receiving a diagnosis and finding high-quality, supportive care can be difficult: close to 70 percent of PCOS cases are undiagnosed, and it can take an average of ten years to receive an endometriosis diagnosis. Moreover, a study from KFF of women ages 18-64 found that close to 30 percent felt that their doctor had dismissed their concerns, leaving women to manage symptoms and long-term side effects on their own.

“Allara was built for the tens of millions of women living with complex hormonal and gynecologic conditions across the U.S., myself included,” said founder and CEO Rachel Blank. “After receiving a PCOS diagnosis without sufficient medical support, I realized firsthand the inequities that exist for many of us throughout the healthcare system. At Allara, we ensure women struggling with hormonal conditions can access affordable care that answers questions, minimizes symptoms, and helps them live fulfilling lives – and we are incredibly grateful for the support from our investors as we deliver on this mission.”

Allara’s team of experts, including OB-GYNs, endocrinologists, nurse practitioners, and Registered Dietitians, takes a whole-body approach to patient care, virtually delivering evidence-based solutions to help patients feel better faster. For its thousands of patients nationwide, Allara offers expert-led care plans that combine medical expertise, lifestyle management, and community support – creating treatment programs personalized to individuals and their unique needs. Within a few weeks of treatment from Allara, over 75% of patients report feeling more in control of their health, empowered about their care, and hopeful about their outcomes.

2024 was a landmark year for Allara. The company grew by 4x, officially launched its care model across all 50 U.S. states, and forged new insurance partnerships with health plans including Aetna, Blue Cross Blue Shield, Cigna, Humana, and United Healthcare. Allara also invested in its clinical leadership, welcoming new Chief Medical Officer Dr. Heather Huddleston, a specialist in reproductive endocrinology and infertility and director of the UCSF PCOS Clinic and research program. Dr. Huddleston will deepen Allara’s established clinical expertise and lead forays into new areas of care in the coming years.

“The challenges that women face in healthcare have been overlooked and underappreciated for too long,” said Martin Mingot, Partner at Index Ventures. “Allara has created a new way for women to engage with specialty care: personalized treatment delivered at scale by a team of experts who care deeply about their patients. As the healthcare market makes the jump from offline to online – similar to what we saw with consumer internet 20 years ago – there’s a significant opportunity to provide better access to care for patients and better quality of life for providers.” 

For more information about Allara, please visit allarahealth.com.

About Allara Health

Allara is a specialty care platform built for the tens of millions of women living with complex hormonal and gynecologic conditions, such as polycystic ovary syndrome (PCOS) and endometriosis. Allara makes expert healthcare accessible online by connecting patients with expert medical practitioners and Registered Dietitians who have a deep understanding of hormonal and metabolic care. Allara provides ongoing medical, lifestyle, and emotional support for chronic conditions, helping patients see improved health outcomes and achieve their individualized goals. To learn more about Allara, visit www.allarahealth.com.

SOURCE Allara Health

Copyright © 2025 Cision US Inc.


Venture Capital
Allara Health, Cision, New York, PRNewswire, Venture Capital

Post navigation

NEXT
Creator Marketing Platform ShopMy Raises $77.5M to Pioneer Performance-First Approach
PREVIOUS
Recycle Track Systems Secures Financing to Accelerate AI Innovation and Expand Sustainable Waste Solutions Across North America
Comments are closed.
Subscribe for FREE!

intelligence360

intelligence360
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Kimberly-Clark Corporation, one of the world's leading manufacturers of personal care and hygiene products, will establish an $800 million advanced manufacturing facility in Trumbull County, bringing an anticipated 491 new high-quality jobs. For Kimberly-Clark, this new facility would be its first in Ohio and represents not just a strategic expansion, but a decisive step in doubling down on growth in the American market. Spread across more than one million square feet, the Warren facility will provide the manufacturing capacity needed to unleash future growth for Kimberly-Clark’s fastest-growing personal care categories that include Baby & Child Care and Adult & Feminine Care. Warren is in geographic proximity to roughly 117 million consumers and will serve as a strategic hub for the Northeast and Midwest regions. Construction is expected to begin this month and will take up to two years.

In a statement Tamera Fenske, chief supply chain officer at Kimberly-Clark said, “Our investment in Warren is a pivotal step forward in our North America business and strategy.” “By establishing a new, state-of-the-art manufacturing facility in Ohio, we’re enhancing our ability to serve millions of consumers across the Midwest and Northeast with greater speed, agility, and resilience. It’s a once-in-a-career opportunity to build a facility from the ground up that reflects the future of manufacturing, and with the support of local partners like JobsOhio, the Department of Development, Lake to River, Western Reserve Port Authority, and local governments, we have the unique opportunity to create high-quality jobs and long-term economic impact in the region.”

Based in Dallas and employing 46,000 people in 34 countries, the company’s portfolio of brands also includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll. Its products are sold in more than 175 countries and territories.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Snorkel AI announced general availability of two new product offerings on the Snorkel AI Data Development Platform: Snorkel Evaluate and Snorkel Expert Data-as-a-Service. These launches advance its mission to turn knowledge into specialized AI—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. In addition, Snorkel AI announced it has raised $100 million in Series D funding at a $1.3 billion valuation, led by Addition. This new funding will fuel continued research and innovation in evaluating and tuning specialized AI systems with expert data.


In a statement Alex Ratner, Co-founder and CEO of Snorkel AI said, “We are seeing a surge of momentum around agentic AI, but specialized enterprise agents aren’t ready for production in most settings.” “Enterprises need domain-specific data and expertise to make this a reality. We’re excited to deliver on this need and help AI innovators develop expert data to bring their LLM and agentic systems into production with our new offerings, which round out Snorkel’s unified AI data development stack.”

Snorkel AI is building the Snorkel AI Data Development Platform for evaluating and tuning specialized AI at scale. Snorkel AI’s offerings, including Snorkel Evaluate and Snorkel Expert Data-as-a-Service, accelerate evaluation and tuning of specialized AI systems with expert data—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. Launched out of the Stanford AI Lab, Snorkel AI’s platform is used in production by Fortune 500 companies, including BNY, Wayfair, and Chubb, as well as across the U.S. federal government, including the U.S. Air Force.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

TicketManager, a global leader in event ticket and guest management solutions for the corporate enterprise, today announced Valeas Capital Partners, a growth-oriented private-equity firm, has acquired a majority stake in the company. Under the terms of the agreement, Valeas is committing $110 million to support TicketManager’s strategic growth plans. TicketManager Co-Founder and CEO Tony Knopp and COO Ken Hanscom will retain a minority interest in the Company. Founded in 2007, TicketManager is the category leader in providing software and services to manage end-to-end event ticket workflow and guest experiences. Serving as the central hub and system of record for data-driven organizations, the platform streamlines every step of the ticket management process. Every year, companies spend more than $600 billion on customer entertainment, yet 43% of corporate tickets are never used and fewer than 20% of organizations leverage modern software to optimize those investments and mitigate compliance risk.

In a statement Tony Knopp, CEO and Co-Founder of TicketManager said, “Live events are an important investment for businesses of all sizes. Whether major global sponsorships, naming rights for stadiums, luxury suites or even a few season tickets for the local team, companies use them to attract and keep customers while building their brands. But in today’s market, many companies struggle with growing pressure to show the value of their ticket spending.” “We knew there was a better way, and that’s why we created TicketManager – to make company tickets easy and prove the return on investment with cutting edge technology and services.”

TicketManager is a leading event- and guest-management platform that empowers companies to make client entertainment easy and drive greater return on investment. It offers convenient and simple technology to manage corporate sports and entertainment tickets, create exceptional guest life-cycle experiences, and measure effectiveness. TicketManager is trusted by more than 500 global brands including Verizon, FedEx, Adidas, Anheuser-Busch, and Mastercard.
Load More... Subscribe

Categories

Recent Posts

  • Bespoken Spirits Announces Successful Close of Series-C Funding Round June 9, 2025
  • Bito Raises $5.7M Seed Extension to Expand AI Code Review Platform with Codebase Awareness June 9, 2025
  • Pillar Biosciences Raises $34.5M in Funding June 9, 2025
  • CloudZero Raises $56M Series C To Redefine Cloud Cost Optimization In The AI Era June 9, 2025

Archives

© 2025   Copyright SI360 Inc. All Rights Reserved.